Sanofi becomes latest drugmaker to announce insulin price cuts, capping cost at $35 for the privately insured

CNN  —  Sanofi is cutting the list price of Lantus, its most widely prescribed insulin in the US, by 78% and establishing a $35 monthly cap for those with private…

Less than a third of insured hepatitis C patients get timely treatment, study shows

The researchers on the study, published Tuesday by the US Centers for Disease Control and Prevention, found that among about 48,000 people who tested positive for the potentially life-threatening disease…